TrialRMD open2026

Improvements in quality-of-life dimensions through medium-chain triglyceride (MCT) supplementation in rheumatoid arthritis: updated findings from a randomised clinical trial.

Giulia Gaudioso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.